1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. Financials
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
Delayed Australian Stock Exchange  -  02:11 2022-08-12 am EDT
0.1850 AUD   -5.13%
08/06RESAPP HEALTH : Pfizer raises scheme consideration to A$0.208 per share
PU
07/22RESAPP HEALTH : Study shows efficacy of ResAppDx use with masks
PU
07/21ResApp Health Validates Effectivity of Respiratory Diagnostic App in Mask-Wearing Patients; Shares Fall 4%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Valuation
Fiscal Period: June 2016 2017 2018 2019 2020 2021
Capitalization1 24019489,013512935,2
Enterprise Value (EV)1 22618685,613012328,8
P/E ratio -56,7x-19,3x-13,6x-24,6x-14,6x-4,71x
Yield ------
Capitalization / Revenue -----505 185 355x
EV / Revenue -----413 455 192x
EV / EBITDA --18 656 383x-13 202 729x-24 037 646x-14 708 399x-4 341 720x
Price to Book 15,0x17,1x16,1x17,6x18,4x4,63x
Nbr of stocks (in thousands) 648 821659 040659 040693 131735 119859 197
Reference price () 0,370,300,140,200,180,04
Announcement Date 09/28/201609/29/201709/28/201808/28/201908/31/202008/26/2021
1 AUD in Million
Income Statement Evolution (Annual data)
Fiscal Period: June 2016 2017 2018 2019 2020 2021
Net sales -----0,07
EBITDA --9,96-6,48-5,39-8,38-6,64
Operating profit (EBIT)1 -3,29-10,2-6,62-5,53-8,52-6,79
Operating Margin ------9 739%
Pre-Tax Profit (EBT)1 -3,21-10,0-6,53-5,44-8,47-6,77
Net income1 -3,21-10,0-6,53-5,44-8,47-6,77
Net margin ------9 715%
EPS2 -0,01-0,02-0,01-0,01-0,01-0,01
Dividend per Share ------
Announcement Date 09/28/201609/29/201709/28/201808/28/201908/31/202008/26/2021
1 AUD in Million
2 AUD
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2019 S2
Net sales1 2,33
EBITDA1 -2,04
Operating profit (EBIT) -
Operating Margin -
Pre-Tax Profit (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 08/28/2019
1 AUD in Million
Balance Sheet Analysis
Fiscal Period: June 2016 2017 2018 2019 2020 2021
Net Debt1 ------
Net Cash position1 13,78,553,405,525,456,40
Leverage (Debt / EBITDA) -0,86x0,52x1,02x0,65x0,96x
Free Cash Flow1 -5,12-1,81-2,75-2,95-1,11-3,19
ROE (Net Profit / Equities) -38,8%-73,2%-77,4%-82,2%-115%-92,8%
Shareholders' equity1 8,2713,78,456,617,347,30
ROA (Net Profit / Asset) -19,5%-45,2%-44,8%-43,6%-58,3%-46,4%
Assets1 16,422,214,612,514,514,6
Book Value Per Share2 0,020,020,010,010,010,01
Cash Flow per Share2 0,020,010,010,010,010,01
Capex ---0,040,010,05
Capex / Sales -----66,2%
Announcement Date 09/28/201609/29/201709/28/201808/28/201908/31/202008/26/2021
1 AUD in Million
2 AUD
Key data
Capitalization (AUD) 159 043 959
Capitalization (USD) 112 965 380
Net sales (AUD) 69 731
Net sales (USD) 49 528
Number of employees 510
Sales / Employee (AUD) 137
Sales / Employee (USD) 97,1
Free-Float 81,0%
Free-Float capitalization (AUD) 128 835 370
Free-Float capitalization (USD) 91 508 893
Avg. Exchange 20 sessions (AUD) 1 427 616
Avg. Exchange 20 sessions (USD) 1 014 004
Average Daily Capital Traded 0,90%
EPS & Dividend